The clinical evidence

What the human and animal studies actually found

This is the unit where enthusiasm meets the record. Ipamorelin has one rigorous human pharmacokinetic study, one well-conducted Phase II efficacy trial, and a handful of preclinical animal studies. That is the entire serious dataset, and it tells a more sobering story than the marketing.

We walk the Phase I pharmacokinetics, the negative postoperative-ileus trial that is the only real efficacy test ever published, the preclinical bone and growth work, and how to place all of it on an honest evidence hierarchy. The headline: strong pharmacology, one failed outcome trial, no approved use.